Crosscheck

Your medical. Crosschecked.

Check another medication

Asthma and breathing

Daily asthma controller medication and your FAA medical

Inhaled corticosteroid, inhaled long-acting beta agonist, or a combination inhaler of the two
Other names: fluticasone inhaler, Flovent, budesonide inhaler, Pulmicort, Advair, Symbicort

FAA guidance

Acceptable with conditions.

Source: FAA, Asthma Disposition Table. FAA date 24 September 2025. Checked by Crosscheck 11 November 2026

The FAA documents quoted here name the class, not this medication. Crosscheck matched it through its class: Inhaled corticosteroid, inhaled long-acting beta agonist, or a combination inhaler of the two.

The FAA's asthma table sends intermittent or mild persistent asthma to its CACI – Asthma Worksheet, which it says requires a current, detailed clinical progress note and spirometry.

Track your medications
Compare FAA documents: Daily asthma controller medicationWhat each of the two FAA documents says, in plain wordsOpen

If the pilot meets all CACI worksheet criteria and is otherwise qualified, the examiner can issue with no time limitation. The worksheet's acceptable medications are one or more of an inhaled long-acting beta agonist, an inhaled short-acting beta agonist (for example albuterol), an inhaled corticosteroid and a leukotriene receptor antagonist (for example montelukast); it says monoclonal antibodies are not acceptable for CACI.

Show the FAA's words: Daily asthma controller medicationThe official FAA wording: two passages, each with its document and dateOpen
FAA, Asthma Disposition Table · FAA date 24 September 2025
B. Intermittent or mild persistent See the CACI -Asthma Worksheet. This requires a current, detailed Clinical Progress Note and spirometry. If the pilot meets all CACI worksheet criteria and is otherwise qualified: If the pilot meets all CACI worksheet criteria and is otherwise qualified, ISSUE With no time limitation
FAA, CACI – Asthma Worksheet · FAA date 24 September 2025
Acceptable Medications
NOT acceptable for CACI:
Monoclonal antibodies
One or more of the following
Inhaled long-acting beta agonist
Inhaled short-acting beta agonist (e.g., albuterol)
Inhaled corticosteroid
leukotriene receptor antagonist, (e.g. montelukast [Singulair])
Sources and dates: Daily asthma controller medicationTwo FAA documents, with the FAA's date and when Crosscheck checked themOpen

Questions pilots ask

Each answer is built from the FAA guidance on this page. Its sources and dates are in the page.

What does the FAA say about daily asthma controller medication for pilots?

FAA guidance: Acceptable with conditions. The FAA's asthma table sends intermittent or mild persistent asthma to its CACI – Asthma Worksheet, which it says requires a current, detailed clinical progress note and spirometry. If the pilot meets all CACI worksheet criteria and is otherwise qualified, the examiner can issue with no time limitation. Crosscheck does not predict the FAA's decision.

What else does the FAA's guidance say about daily asthma controller medication?

The worksheet's acceptable medications are one or more of an inhaled long-acting beta agonist, an inhaled short-acting beta agonist (for example albuterol), an inhaled corticosteroid and a leukotriene receptor antagonist (for example montelukast); it says monoclonal antibodies are not acceptable for CACI.

Related pages

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.